HK19595A - Fluoxetine useful for the treatment of diabetes - Google Patents

Fluoxetine useful for the treatment of diabetes

Info

Publication number
HK19595A
HK19595A HK19595A HK19595A HK19595A HK 19595 A HK19595 A HK 19595A HK 19595 A HK19595 A HK 19595A HK 19595 A HK19595 A HK 19595A HK 19595 A HK19595 A HK 19595A
Authority
HK
Hong Kong
Prior art keywords
fluoxetine
diabetes
patients
day
treatment
Prior art date
Application number
HK19595A
Other languages
German (de)
English (en)
French (fr)
Inventor
Taiwai Wong David
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HK19595A publication Critical patent/HK19595A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
HK19595A 1987-05-04 1995-02-09 Fluoxetine useful for the treatment of diabetes HK19595A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4550987A 1987-05-04 1987-05-04

Publications (1)

Publication Number Publication Date
HK19595A true HK19595A (en) 1995-02-17

Family

ID=21938301

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19595A HK19595A (en) 1987-05-04 1995-02-09 Fluoxetine useful for the treatment of diabetes

Country Status (11)

Country Link
EP (1) EP0294028B1 (da)
JP (1) JP2721507B2 (da)
KR (1) KR880013555A (da)
AT (1) ATE93721T1 (da)
AU (1) AU596296B2 (da)
DE (1) DE3883606T2 (da)
DK (1) DK238588A (da)
ES (1) ES2058272T3 (da)
HK (1) HK19595A (da)
PH (1) PH23901A (da)
ZA (1) ZA883115B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449562A3 (en) * 1990-03-29 1992-03-18 Eli Lilly And Company Use of r-fluoxetine as selective serotonin ic-receptor ligands
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
WO2004096201A1 (en) 2003-04-29 2004-11-11 Orexigen Therapeutics, Inc. Compositions for affecting weight loss
ES2761812T3 (es) * 2005-11-22 2020-05-21 Nalpropion Pharmaceuticals Inc Composición y métodos de aumento de la sensibilidad a la insulina
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR20150082689A (ko) 2006-11-09 2015-07-15 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
DK2089005T3 (da) 2006-11-09 2010-07-19 Orexigen Therapeutics Inc Lagdelte farmaceutiske formuleringer omfattende et hurtigt opløsende mellemlag
WO2009158114A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
CN102724878A (zh) 2010-01-11 2012-10-10 奥雷西根治疗公司 在重度抑郁症患者中提供体重减轻疗法的方法
HUE072188T2 (hu) 2012-06-06 2025-10-28 Nalpropion Pharmaceuticals Llc Készítmény magas kardiovaszkuláris kockázatú túlsúlyos és elhízott páciensek kezelésére szolgáló eljárásban történõ alkalmazásra
EA201590047A1 (ru) 2012-07-31 2015-09-30 Сановел Хайван Саглиги Юрюнлери Санайи Ве Тиджарет А.С. Применение флуоксетина для увеличения мясной и молочной продуктивности
EA201590044A1 (ru) 2012-07-31 2015-09-30 Сановел Хайван Саглиги Юрюнлери Санайи Ве Тиджарет А.С. Применение флуоксетина у животных
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
ZA861211B (en) * 1985-02-25 1987-10-28 Lilly Co Eli Analgesic composition

Also Published As

Publication number Publication date
EP0294028A3 (en) 1990-05-02
EP0294028A2 (en) 1988-12-07
DE3883606D1 (de) 1993-10-07
DE3883606T2 (de) 1994-01-20
AU1553388A (en) 1988-11-10
ATE93721T1 (de) 1993-09-15
AU596296B2 (en) 1990-04-26
JPS63284126A (ja) 1988-11-21
DK238588A (da) 1988-11-05
ES2058272T3 (es) 1994-11-01
ZA883115B (en) 1990-01-31
PH23901A (en) 1989-12-18
KR880013555A (ko) 1988-12-21
DK238588D0 (da) 1988-05-03
EP0294028B1 (en) 1993-09-01
JP2721507B2 (ja) 1998-03-04

Similar Documents

Publication Publication Date Title
EP0294028B1 (en) Fluoxetine useful for the treatment of diabetes
Wynne et al. Oral amrinone in refractory congestive heart failure
EP1017408B1 (en) Use of tethrahydrolipstatin in the treatment of diabetes type ii
KR100422162B1 (ko) 케토코나졸을포함하는당뇨병타입ii의치료용약제
Hesse et al. Hypoglycaemia after propranolol in children
EA015382B1 (ru) Применение рофлумиласта для лечения сахарного диабета типа 2
JP2008509145A (ja) 抗糖尿病性経口インスリン−ビグアニドの組み合わせ
Brodie et al. Observations on G-25671, A Phenylbutazone Analogue (4-(phenylthioethyl)− 1, 2-diphenyl 3, 5-pyrazolidinedione).
KR100709528B1 (ko) 혈당콘트롤용 의약조성물
JPH08512311A (ja) 慢性疲労症候群治療用ヒ素医薬
Kadhe et al. Advances in drug delivery of oral hypoglycemic agents
Samanta et al. Improved effect of tolbutamide when given before food in patients on long-term therapy
CN121398832A (zh) 用于药物疗法的司美格鲁肽
KR0171188B1 (ko) 당뇨병 치료용 제약 조성물
US20210100872A1 (en) Pharmacological Formulation Comprising Cyclo (HIS-PRO) As Effective Ingredient For Preventing Or Treating Diabetes Mellitus
CN119157885B (zh) 18β-甘草次酸用于提高肾性贫血造血能力的用途
BEEBE et al. Fatal agranulocytosis during treatment of toxic goiter with propylthiouracil
KR100709531B1 (ko) 당뇨병성 합병증의 예방 또는 진전저지용 의약조성물
TWI912639B (zh) 含有氮雜環化合物之藥物組合物及其用於製備藥物的用途
EP0005733A1 (en) Pharmaceutical compositions for use in the treatment of diabetic nephropathy and method for preparing them
CN114099493B (zh) 一种抑制胰岛素抵抗的活性化合物及其应用
US3969525A (en) Method for reducing the heart beat frequency
Parodi et al. Long-term treatment of diabetes with glipizide
Castro Xipamide (‘Diurexan’) in essential hypertension: A 24-month study
US4810696A (en) Diethylaminoethyl dextran for decreasing hyperglycemia

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)